InspireMD (NSPR) Work In Process (2012 - 2025)

InspireMD's (NSPR) quarterly Work In Process came in at $930000.0 in Q4 2025, up 45.77% year-on-year from $638000.0 in Q4 2024, and up 26.88% quarter-over-quarter from $733000.0 in Q3 2025.

InspireMD (NSPR) Work In Process (2012 - 2025) Analysis & Trends

InspireMD's Work In Process history runs 14 years deep, the most recent figure standing at $930000.0 for Q4 2025.

  • On a quarterly basis, Work In Process rose 45.77% year-over-year to $930000.0 in Q4 2025; TTM through Dec 2025 was $930000.0, a 45.77% increase from a year earlier, with the FY2025 full-year figure at $930000.0, up 45.77% from the prior year.
  • Work In Process rose to $930000.0 in Q4 2025 per NSPR's latest filing, from $733000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $930000.0 in Q4 2025 and bottomed at $223000.0 in Q1 2021.
  • The 5-year median for Work In Process is $537000.0 (2024), against an average of $556315.8.
  • Across the five-year window, Work In Process dropped 20.64% in 2021 and jumped 122.87% in 2022, its largest moves.
  • Year by year, Work In Process stood at $436000.0 in 2021, then advanced by 16.97% to $510000.0 in 2022, then increased by 10.2% to $562000.0 in 2023, then advanced by 13.52% to $638000.0 in 2024, then jumped by 45.77% to $930000.0 in 2025.
  • Per Business Quant, the three latest NSPR Work In Process figures stand at $930000.0 (Q4 2025), $733000.0 (Q3 2025), and $865000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 InspireMD 2,073.45 -54.21 Mn 1.18 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 930,000.00
Sep 30, 2025 733,000.00
Jun 30, 2025 865,000.00
Mar 31, 2025 823,000.00
Dec 31, 2024 638,000.00
Sep 30, 2024 557,000.00
Jun 30, 2024 537,000.00
Dec 31, 2023 562,000.00
Sep 30, 2023 634,000.00
Jun 30, 2023 513,000.00
Mar 31, 2023 690,000.00
Dec 31, 2022 510,000.00
Sep 30, 2022 347,000.00
Jun 30, 2022 414,000.00
Mar 31, 2022 497,000.00
Dec 31, 2021 436,000.00
Sep 30, 2021 329,000.00
Jun 30, 2021 332,000.00
Mar 31, 2021 223,000.00
Dec 31, 2020 376,000.00